Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells

Endocytosis at the nanoscale

(2012) Irene Canton et al.   CHEMICAL SOCIETY REVIEWS

Kinetically Controlled Cellular Interactions of Polymer−Polymer and Polymer−Liposome Nanohybrid Systems

(2011) Suhair Sunoqrot et al.   BIOCONJUGATE CHEMISTRY

Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells

(2011) Gordon P. Meares et al.   EXPERIMENTAL CELL RESEARCH

Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases

(2011) D. Cosco et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A Hydrophobic Starch Polymer for Nanoparticle-Mediated Delivery of Docetaxel

(2011) Prajakta Dandekar et al.   MACROMOLECULAR BIOSCIENCE

Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism

(2011) M Donadelli et al.   Cell Death & Disease

Chitosan and Glyceryl Monooleate Nanostructures Containing Gemcitabine: Potential Delivery System for Pancreatic Cancer Treatment

(2010) William J. Trickler et al.   AAPS PHARMSCITECH

Hand–Foot Hyperpigmentation Skin Lesions Associated With Combination Gemcitabine–Carboplatin (GemCarbo) Therapy

(2010) Roman L Kleynberg et al.   AMERICAN JOURNAL OF THERAPEUTICS

The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability

(2010) Archibald Paillard et al.   BIOMATERIALS

Giant Mitochondria in the Myocardium of a Patient With Mitochondrial Cardiomyopathy

(2010) Yumiko Kanzaki et al.   CIRCULATION

Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation

(2010) Barbara Pili et al.   Nanoscale

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis

(2009) Rania Harfouche et al.   ANGIOGENESIS

In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer

(2009) Donato Cosco et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Pancreatic cancer: Current and future treatment strategies

(2009) K. Pliarchopoulou et al.   CANCER TREATMENT REVIEWS

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells

(2009) Sung Pil Hong et al.   INTERNATIONAL JOURNAL OF CANCER

Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines

(2009) Wu Huanwen et al.   Molecular Cancer

Ultrasonic Nanotherapy of Pancreatic Cancer: Lessons from Ultrasound Imaging

(2009) Natalya Rapoport et al.   MOLECULAR PHARMACEUTICS

Physico-Chemical Characteristics of Lipoplexes Influence Cell Uptake Mechanisms and Transfection Efficacy

(2009) Sarah Resina et al.   PLoS One

Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

(2009) S. Basu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Compendium of Potential Biomarkers of Pancreatic Cancer

(2009) H. C. Harsha et al.   PLOS MEDICINE

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent

(2008) C. R. Patra et al.   CANCER RESEARCH

Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer

(2008) Flora Stavridi et al.   Expert Review of Anticancer Therapy

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY